Tigatuzumab, CAS 918127-53-4

Product Description: Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Yamamoto J, et al. Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model. Cancer Lett. 2020 Nov 1;492:174-184.

CAS Number: 918127-53-4

Molecular Weight: 144.6 (kDa)

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Apoptosis

• Artikelnummer: MEXHY-P99270-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99270-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK